证券代码：301045 证券简称：天禄科技 公告编号：2025-048 苏州天禄光科技股份有限公司 第三届监事会第二十七次会议决议公告 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、监事会会议召开情况 表决结果：3 票同意，0 票反对，0 票弃权。 经审核，监事会认为本次计提资产减值准备符合《深圳证券交易所上市公司 自律监管指引第 2 号——创业板上市公司规范运作》及《企业会计准则》等相关 规定，真实、准确的反映了公司的资产及财务状况，不存在损害公司及全体股东 特别是中小股东利益的情形。监事会同意公司本次计提资产减值准备相关事项。 具体内容详见同日公司披露在巨潮资讯网（http://www.cninfo.com.cn）上的 《关于 2025 年半年度计提资产减值准备的公告》。 苏州天禄光科技股份有限公司（以下简称"公司"）第三届监事会第二十七 次会议的通知于 2025 年 8 月 15 日以邮件、即时通讯工具等方式发出。本次会议 于 2025 年 8 月 25 日在公司会议室以现场表决方式召开。本次会议应出席监事 3 人，实际出席监事 3 人。会议由公司 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 一、重要提示 本半年度报告摘要来自半年度报告全文，为全面了解本公司的经营成果、财务状况及未来发展规划，投 资者应当到证监会指定媒体仔细阅读半年度报告全文。 所有董事均已出席了审议本报告的董事会会议。 非标准审计意见提示 □适用 √不适用 董事会审议的报告期利润分配预案或公积金转增股本预案 □适用 √不适用 公司计划不派发现金红利，不送红股，不以公积金转增股本。 证券代码：000055、200055 证券简称：方大集团、方大B 公告编号：2025-21 董事会决议通过的本报告期优先股利润分配预案 □适用 √不适用 公司是否需追溯调整或重述以前年度会计数据 □是 √否 ■ 3、公司股东数量及持股情况 单位：股 ■ 持股5%以上股东、前10名股东及前10名无限售流通股股东参与转融通业务出借股份情况 □适用 √不适用 前10名股东及前10名无限售流通股股东因转融通出借/归还原因导致较上期发生变化 公司报告期实际控制人未发生变更。 5、公司优先股股东总数及前10名优先股股东持股情况表 □适用 √不适用 □适用 √不适用 4、控股股东或实际控制人变更情况 控股股东报告期内 ...

证券代码：603976 证券简称：正川股份 公告编号：2025-050 债券代码：113624 债券简称：正川转债 重庆正川医药包装材料股份有限公司 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、监事会会议召开情况 重庆正川医药包装材料股份有限公司（以下简称"公司"）于 2025 年 8 月 议的通知。会议于 2025 年 8 月 22 日以现场方式在正川永成三楼会议室召开，应 参加监事 3 名，实际参加监事 3 名。 本次会议由监事王志伟先生召集和主持，公司相关人员列席了会议。本次会 议的召集、召开和表决程序均符合《公司法》等法律、行政法规以及《公司章程》 《公司监事会议事规则》的有关规定，会议的召集、召开合法有效。 监事会认为：公司本次计提资产减值准备是按照《企业会计准则》和公司相 关会计政策进行，能够更加真实、公允地反映公司的资产价值和财务状况，决策 程序符合相关法律法规和《公司章程》的有关规定,不存在损害公司及全体股东， 特别是中小股东利益的情况。监事会同意本次计提资产减值准备事项。 表决结果：3 票同意、0 票 ...

证券代码：002051 证券简称：中工国际 公告编号：2025－043 中工国际工程股份有限公司 本公司及监事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 中工国际工程股份有限公司（以下简称"公司"）第八届监事会 第三次会议通知于2025年8月11日以专人送达、电子邮件方式向全体 监事发出，会议于2025年8月21日上午10:30在公司1606会议室以现场 和通讯相结合的方式召开，应到监事三名，实到监事三名，其中监事 李金伟以通讯方式出席会议，出席会议的监事占监事总数的100%， 符合《中华人民共和国公司法》和《公司章程》的规定。会议由监事 会主席周寅伦先生主持。 本次会议以举手表决和记名投票方式审议了如下决议： 年中工作报告》 提资产减值准备的议案》。 监事会对《关于计提资产减值准备的议案》进行了审核，监事会 认为：公司本次计提资产减值准备符合《企业会计准则》相关会计政 —1— 策的规定及公司实际情况，计提减值准备的依据充分，能更加客观公 允地反映公司资产状况和经营成果，不存在损害公司及全体股东利益 的情况，监事会同意本次计提资产减值准备。 有关内容详见同日公司在《中 ...

Core Points - The supervisory board of Jilin Quanyangquan Co., Ltd. held its seventh meeting of the ninth supervisory board on August 22, 2025, to review the company's semi-annual report for 2025 [1][2] - The supervisory board confirmed that the semi-annual report was prepared in accordance with legal regulations and internal management systems, accurately reflecting the company's operational and financial status [1][2] - The board approved cash management strategies to enhance the efficiency of fund utilization, allowing investments in safe financial products with a maximum term of 12 months [2] - The board agreed to recognize asset impairment provisions to provide a more accurate representation of the company's asset status [2] Meeting Details - The meeting was attended by all five supervisors, ensuring a legal and effective assembly [1] - The voting results for all resolutions were unanimous, with 5 votes in favor and no opposition or abstentions [2] Financial Management - The company aims to improve fundraising efficiency and increase returns on funds while ensuring that cash management does not affect ongoing projects [2] - The board's decision on asset impairment provisions aligns with the enterprise accounting standards and relevant accounting policies [2]

证券代码：002421 证券简称：达实智能 公告编号：2025-064 表决情况：3 票同意，0 票反对，0 票弃权。 经审核，监事会认为董事会编制和审核公司《2025 年半年度报告》的程序 符合法律、行政法规和中国证监会的规定，报告内容真实、准确、完整地反映了 上市公司的实际情况，不存在任何虚假记载、误导性陈述或者重大遗漏。 具体内容详见公司于 2025 年 8 月 15 日登载于《证券时报》《证券日报》 和巨潮资讯网（http://www.cninfo.com.cn）的《2025 年半年度报告摘要》 及登载于巨潮资讯网（http://www.cninfo.com.cn）的《2025 年半年度报告》。 深圳达实智能股份有限公司 第八届监事会第十六次会议决议公告 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导 性陈述或重大遗漏。 一、 会议召开情况 深圳达实智能股份有限公司（以下简称"公司"）第八届监事会第十六次会 议通知于 2025 年 8 月 3 日以电子邮件的方式发送至全体监事，于 2025 年 8 月 13 日上午采取现场会议的方式召开，现场会议召开地点为公司会议室，会议 ...

Core Viewpoint - The company, Henan Shijia Photon Technology Co., Ltd., has announced an increase in the expected daily related transaction limit for 2025, amounting to 28 million yuan, which is deemed necessary for its normal business operations and will not adversely affect its financial status or operating results [3][4][18]. Group 1: Company Overview - The company is identified by the stock code 688313 and is referred to as Shijia Photon [1]. - The board of directors guarantees the authenticity, accuracy, and completeness of the semi-annual report [1]. Group 2: Financial Data - The company reported a total asset impairment loss of 16.3583 million yuan for the first half of 2025, which includes credit impairment losses of 4.6612 million yuan and inventory impairment losses of 11.5848 million yuan [21][22][23]. Group 3: Daily Related Transactions - The company has approved an increase in the expected daily related transaction limit for 2025, which is necessary for its business development and complies with fair pricing principles [3][4][18]. - The related transactions are conducted under fair market conditions and do not harm the interests of shareholders, particularly minority shareholders [5][7]. Group 4: Cash Management - The company plans to use up to 400 million yuan of temporarily idle self-owned funds for cash management, aiming to enhance fund utilization efficiency without affecting normal business operations [26][27][30]. - The cash management will involve low-risk financial products, ensuring safety and liquidity [31][33].

Core Viewpoint - The company reported a decline in revenue and net profit for the year 2024, primarily due to falling prices of pesticide products, despite an increase in production and sales volume [18]. Group 1: Company Overview - The company, Haier Pharmaceutical Group Co., Ltd., is engaged in the research, production, and sales of pesticide formulations, intermediates, and raw materials, with a focus on insecticides and fungicides [4][15]. - The pesticide industry is characterized by relatively inelastic demand, playing a crucial role in agricultural production and food security [2][3]. Group 2: Financial Performance - The company achieved operating revenue of CNY 3.91 billion in 2024, a decrease of 11.16% from CNY 4.40 billion in 2023 [18]. - The net profit attributable to shareholders was CNY 181.37 million, down 61.67% from CNY 473.20 million in the previous year [18]. - The net cash flow from operating activities was CNY 285.55 million, a significant decrease of 70.11% compared to CNY 955.35 million in 2023 [18]. Group 3: Market Dynamics - The global demand for pesticides is expected to grow due to increasing food security needs and agricultural efficiency [2]. - China's pesticide production capacity is shifting towards countries like China and India, driven by the expiration of patents and restructuring by multinational agrochemical giants [2][3]. Group 4: Product Development - The company has been diversifying its pesticide offerings, with several new products entering trial production in recent years, including various insecticides and fungicides [4][5]. - The company is focusing on high-efficiency, low-toxicity pesticides to meet the growing market demand [2][4]. Group 5: Industry Trends - The pesticide industry is experiencing a shift towards biopesticides and environmentally friendly products, with increasing market share for biological and chemical pesticides [7]. - The market for generic pesticides is expected to expand as patents expire, providing opportunities for companies with strong R&D capabilities [2][3].

Group 1 - The company has proposed to reappoint Ernst & Young Hua Ming as its financial audit and internal control audit institution for the year 2025, with a term of one year, pending approval at the shareholders' meeting [2][10][11] - Ernst & Young Hua Ming was established in September 1992 and has a strong focus on talent development, with over 1,700 certified public accountants, including more than 500 with experience in securities-related services [2][3] - The audit firm reported a total revenue of RMB 5.955 billion in 2023, with audit service revenue of RMB 5.585 billion and securities service revenue of RMB 2.438 billion [2] Group 2 - The audit firm has a good investor protection capability, having set aside a professional risk fund and purchased professional liability insurance with a total coverage exceeding RMB 200 million [3] - In the past three years, Ernst & Young Hua Ming has not faced any civil lawsuits related to its professional conduct [3][5] - The firm has maintained a clean record with no criminal or administrative penalties in the last three years [5][7] Group 3 - The project partner and lead auditor, Liu Chong, has been a registered accountant since 2010 and has been providing audit services to the company since 2021 [6] - The second signing auditor, Zhao Pu, has been with the firm since 2021 and has also been involved in auditing the company [6] - The quality review partner, Tan Zhao Hui, has extensive experience in auditing and has been with Ernst & Young Hua Ming since 1993 [6] Group 4 - The audit fee for 2024 is set at RMB 2.5411 million, which includes tax, and the fee structure will remain unchanged for 2025 [9] - The audit committee unanimously approved the reappointment of Ernst & Young Hua Ming, citing their adherence to independent and objective auditing standards [10][11] - The board of directors also supported the reappointment, emphasizing the audit firm's professional competence and ethical conduct [11][12] Group 5 - The shareholders' meeting is scheduled for May 16, 2025, to discuss various proposals, including the reappointment of the audit firm [16][17] - The meeting will utilize a combination of on-site and online voting methods [16] - The company has outlined specific procedures for shareholders to register and participate in the meeting [20][22]

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：601933 证券简称：永辉超市 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 □是 √否 一、 主要财务数据 (一) 主要会计数据和财务指标 单位：元 币种：人民币 注1：当期营业收入下滑主要是由于公司主动进行战略和经营模式转型，截至 2025年3月底公司共完成 了47家门店的调改且调改门店迅速大幅提升客流和销售额；由于调改的门店数占比不大，且今年一季度 较去年同期减少了273家门店（关闭尾部门店），使得公司2025年1-3月整体收入有所下滑； 注2：当期归属于上市公司股东的净利润下降主要系毛利率较上年同期下降1.35个百分点，公司在门店 调改过程中主动优化商品结构和采购模式，在淘汰旧品、引入新品的过程中主动推动裸价和控后台的策 略，此过程中，公司整体毛利率受到了一定的影响。随着3月底供应商大会的召开，未来公司选品及定 价策略将发生重大改变，在此基础上，商品毛利率将得到进一步的恢复和增长。另外，公司持有的 Advantage solutions股票本期产生的公允价 ...